Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
https://pubmed.ncbi.nlm.nih.gov/37891838/Actively Recruiting
Led by Danish Research Centre for Magnetic Resonance · Updated on 2026-08-27
100
Participants Needed
1
Research Sites
391 weeks
Total Duration
Researchers are studying early-stage Parkinsons disease PD by focusing on patients with REM sleep behavior disorder RBD, a condition linked to nerve-cell loss in the brainstem. Since over 80% of people with RBD develop Parkinsons disease or related disorders, this study aims to better understand the earliest signs and progression of PD to improve future diagnosis and treatment. The research involves detailed examination of brain changes, abnormal protein buildup, and functional changes related to PD. Participants will undergo advanced brain imaging techniques, such as 7-Tesla MRI, Pe2i-PET, and MIBG-scintigraphy, to assess brain structure and dopamine availability. Sleep and brain activity will be recorded using polysomnography and EEG. Clinical assessments will measure motor skills, cognitive function, and autonomic nervous system responses, including cardiovascular tests like the tilt-table test. The study includes 50 individuals with RBD and 50 age- and gender-matched controls without major neurological or psychiatric conditions. Throughout the study, participants will complete extensive evaluations including sleep studies, imaging scans, cognitive and motor tests, and autonomic function assessments. Researchers will analyze these data to identify early PD biomarkers, such as damage to the locus coeruleus and substantia nigra. The main outcomes focus on brain structure changes and neuromelanin contrast ratios. This observational study aims to enhance early PD detection and support personalized care, with participation lasting until study completion in 2035.
CONDITIONS
A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD
S
Sune G Thomsen, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Danish Research Centre for Magnetic Resonance
Lead Sponsor
Danish Center for Sleep Medicine
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
https://pubmed.ncbi.nlm.nih.gov/37891838/Per Borghammer, Nathalie Van Den Berge
https://pubmed.ncbi.nlm.nih.gov/31498132/Ryuji Sakakibara, Fuyuki Tateno, Yosuke Aiba...
https://pubmed.ncbi.nlm.nih.gov/30746415/Mitchell G Miglis, Jennifer Zitser, Logan Schneider...
https://pubmed.ncbi.nlm.nih.gov/34244806/Christopher F Madelung, Annemette Løkkegaard, Søren A Fuglsang...
https://pubmed.ncbi.nlm.nih.gov/40328786/Christopher F Madelung, David Meder, Søren A Fuglsang...
https://pubmed.ncbi.nlm.nih.gov/35114035/Kathrin Doppler, Hanna-Maria Jentschke, Lena Schulmeyer...
https://pubmed.ncbi.nlm.nih.gov/28180961/Danish Research Centre for Magnetic Resonance
Lead Sponsor
Danish Center for Sleep Medicine
Collaborating Sponsor